2023 annual financial data
Telix Pharmaceuticals 2023 Operating margin
Telix Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was 3.15%.
Operating income was 15,840,000 AUD and net income was 5,211,000 AUD.
Operating cash flow was 23,884,000 AUD.
Get free Telix Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 502,547,000 AUD
- Operating income
- 15,840,000 AUD
- Net income
- 5,211,000 AUD
- Operating cash flow
- 23,884,000 AUD